Protagonist Therapeutics (PTGX) Enters Securities Purchase Agreement for Up 2.75M Shares
Protagonist Therapeutics (NASDAQ: PTGX) disclosed in an SEC filing:On August 6, 2018, Protagonist Therapeutics, Inc. (the “Company”) entered into a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)